NO982032L - Topisk preparat inneholdende capsazepin - Google Patents

Topisk preparat inneholdende capsazepin

Info

Publication number
NO982032L
NO982032L NO982032A NO982032A NO982032L NO 982032 L NO982032 L NO 982032L NO 982032 A NO982032 A NO 982032A NO 982032 A NO982032 A NO 982032A NO 982032 L NO982032 L NO 982032L
Authority
NO
Norway
Prior art keywords
skin
topical preparation
capsazepine
preparation containing
diseases
Prior art date
Application number
NO982032A
Other languages
English (en)
Other versions
NO982032D0 (no
Inventor
Olivier De Lacharriere
Lionel Breton
Original Assignee
Orual L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orual L filed Critical Orual L
Publication of NO982032D0 publication Critical patent/NO982032D0/no
Publication of NO982032L publication Critical patent/NO982032L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/005—Preparations for sensitive skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

Et topisk preparat omfattende capsazepin og som særlig er egnet for behandling av neurogene hudlidelser og sykdommer, særlig smertefull og/eller pruriginøse sykdommer, såvel som for å behandle følsom hud og følsomme øyne. Preparatet er særlig anvendbart for å forhindre og/eller kontrollere hud- og/eller øyeirritasjon, kløe, erytem og dysestesi og varmefornemmelser i huden, øyne og slimhinner, slimhinner, såvel som for å redusere irriterbarheten til en aktiv substans med en irriterende bivirkning.
NO982032A 1995-11-06 1998-05-05 Topisk preparat inneholdende capsazepin NO982032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9513096A FR2740682B1 (fr) 1995-11-06 1995-11-06 Composition topique contenant de la capsazepine
PCT/FR1996/001592 WO1997017077A1 (fr) 1995-11-06 1996-10-11 Composition topique contenant de la capsazepine

Publications (2)

Publication Number Publication Date
NO982032D0 NO982032D0 (no) 1998-05-05
NO982032L true NO982032L (no) 1998-07-06

Family

ID=9484272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982032A NO982032L (no) 1995-11-06 1998-05-05 Topisk preparat inneholdende capsazepin

Country Status (7)

Country Link
US (2) US6048855A (no)
EP (1) EP0859616A1 (no)
JP (1) JPH11501941A (no)
CA (1) CA2234797A1 (no)
FR (1) FR2740682B1 (no)
NO (1) NO982032L (no)
WO (1) WO1997017077A1 (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020867A1 (en) * 1996-11-15 1998-05-22 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Pharmaceutical compositions containing vanilloid agonists in combination with vanilloid antagonists
GB9713484D0 (en) * 1997-06-27 1997-09-03 Smithkline Beecham Plc Neuroprotective vanilloid compounds
JP2001233764A (ja) * 2000-02-22 2001-08-28 Hisamitsu Pharmaceut Co Inc Ｎ−置換−ｏ−トルイジン誘導体からなる鎮痒剤
AU2001282988B2 (en) * 2000-07-26 2006-01-05 Atopic Pty Ltd Methods for treating atopic disorders
US7442369B1 (en) 2000-08-09 2008-10-28 Mcneil Ab Compositions of minoxidil
KR100433940B1 (ko) * 2000-08-22 2004-06-04 주식회사 뉴로넥스 파프 수용체의 활성을 억제하는 캅사제핀을 포함하는 류마티스성 관절염 또는 알러지성 질환의 예방 및 치료용 악제학적 조성물
US20040052826A1 (en) * 2000-09-11 2004-03-18 Elena Fernandez-Kleinlein Cosmetic and pharmaceutical compositions and their use
WO2002019981A2 (en) * 2000-09-11 2002-03-14 Johnson & Johnson Gmbh Cosmetic and pharmaceutical composition comprising chelating/sequestering agents and their cosmetic and dermatological use
US20020142013A1 (en) * 2001-01-31 2002-10-03 Maes Daniel H. Cholesterol sulfate and amino sugar compositions for enhancement of stratum corneum function
US20030225326A1 (en) * 2002-04-03 2003-12-04 Bernard Querleux Methods and combinations relating to information obtained using brain imaging techniques
GB0229808D0 (en) * 2002-12-20 2003-01-29 Glaxo Group Ltd Novel compositions
US7222748B2 (en) * 2003-09-26 2007-05-29 Royal Vendors, Inc. Clear door vending machine
KR20060017571A (ko) * 2004-08-19 2006-02-24 주식회사 태평양 티오우레아 유도체를 함유하는 소양성 또는 자극성피부질환의 예방 또는 치료용 조성물
US20070098665A1 (en) * 2005-10-24 2007-05-03 Shiseido Company, Ltd. Effects of skin surface temperature on the epidermal permeability barrier homeostasis
GB0611417D0 (en) * 2006-06-09 2006-07-19 Leuven K U Res & Dev Treatment of cndaria intoxication
MX2009003022A (es) * 2006-09-21 2009-06-01 Coastal Solutions Inc Composiciones y metodos para tratar picaduras de medusa.
US20080095720A1 (en) * 2006-10-18 2008-04-24 Conopco, Inc., D/B/A Unilever Skin Benefit Compositions with a Vanilloid Receptor Antagonist
US20080300790A1 (en) * 2007-05-29 2008-12-04 James Kirunda Kakaire Environmental data delivery - edd
KR101683042B1 (ko) * 2008-04-04 2016-12-06 포사이트 비젼4, 인크. 통증 관리 및 시력을 위한 치료 장치
EP2490635B1 (en) 2009-10-23 2017-09-06 Nexisvision, Inc. Corneal denervation for treatment of ocular pain
US9498385B2 (en) 2009-10-23 2016-11-22 Nexisvision, Inc. Conformable therapeutic shield for vision and pain
US8591025B1 (en) 2012-09-11 2013-11-26 Nexisvision, Inc. Eye covering and refractive correction methods for LASIK and other applications
US20110159125A1 (en) 2009-12-29 2011-06-30 Avon Products, Inc. CGRP Compositions and Uses Thereof
CN103281995B (zh) 2010-10-25 2016-04-06 内希斯视觉股份有限公司 识别针对视力的眼睛覆盖物的方法和设备
WO2012084870A1 (en) * 2010-12-22 2012-06-28 Galderma Research & Development Modulators and methods for the treatment of rosacea
US8864306B2 (en) 2011-04-28 2014-10-21 Nexisvision, Inc. Eye covering and refractive correction methods and apparatus having improved tear flow, comfort, and/or applicability
US8678584B2 (en) 2012-04-20 2014-03-25 Nexisvision, Inc. Contact lenses for refractive correction
US12044905B2 (en) 2011-04-28 2024-07-23 Journey1 Inc Contact lenses for refractive correction
US9465233B2 (en) 2012-04-20 2016-10-11 Nexisvision, Inc. Bimodular contact lenses
CN104335104B (zh) 2012-04-20 2017-06-09 内希斯视觉股份有限公司 用于屈光矫正的接触透镜
WO2014092684A2 (en) 2012-12-11 2014-06-19 Avon Products, Inc. Use of melicope extracts to improve conditions caused by excess lipids
CA2916885A1 (en) 2013-06-26 2014-12-31 Nexisvision, Inc. Contact lenses for refractive correction
US9341864B2 (en) 2013-11-15 2016-05-17 Nexisvision, Inc. Contact lenses having a reinforcing scaffold
US20150147419A1 (en) * 2013-11-25 2015-05-28 Avon Products, Inc. Compositions of Melicope Elleryana
WO2015116559A1 (en) 2014-01-29 2015-08-06 Nexisvision, Inc. Multifocal bimodulus contact lenses

Also Published As

Publication number Publication date
FR2740682B1 (fr) 1997-12-05
US6262050B1 (en) 2001-07-17
EP0859616A1 (fr) 1998-08-26
WO1997017077A1 (fr) 1997-05-15
FR2740682A1 (fr) 1997-05-09
CA2234797A1 (fr) 1997-05-15
JPH11501941A (ja) 1999-02-16
US6048855A (en) 2000-04-11
NO982032D0 (no) 1998-05-05

Similar Documents

Publication Publication Date Title
NO982032L (no) Topisk preparat inneholdende capsazepin
ATE214931T1 (de) Antibakterielle präparate für die ohren ohne irritierende, sensibilisierende und ototoxische wirkungen
ATE180970T1 (de) Arzneistoffhaltiger tissuepapier
ES2086270T1 (es) Metabolitos de terfenadina y sus isomeros opticamente puros para tratar trastornos alergicos.
ATE153855T1 (de) Zusammensetzungen zur behandlung von glaukoma die prostaglandine und clonidinderivate enthalten
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
KR880000091A (ko) 국소용 약제학적 조성물 이의 제조방법 및 이의 용도
ES2166820T3 (es) Sustancias activas o combinaciones de sustancias activas y preparados contra el envejecimiento de la piel.
NO982006D0 (no) Terapeutisk preparat for transdermal tilf÷rsel av virksomme stoffer gjennom huden
MX9602973A (es) Uso de un antagonista de bradiquinina en una composicion, cosmetica, farmaceutica o dermatologica y la composicion obtenida.
US4670471A (en) Treatment for inflammatory skin disease
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
US7655255B2 (en) Topical composition for transdermal administration
NO942303L (no)
ATE151977T1 (de) Therapeutisch wirksame, örtliche anwendung von st1435
DE69832176D1 (de) Arzneimittel gegen diabetes-komplikationen
KR880007068A (ko) 13-시스 레티노산의 용도
ATE359774T1 (de) Taurinderivate verwendbar in der behandlung von netzhauterkrankungen
KR930019224A (ko) 유산 위험 치료제
ATE120090T1 (de) Behandlung gealterter haut mit oraler 13-cis- retinsäure.
US3862331A (en) Process for treating the skin for relieving symptoms caused by poison ivy and poison oak
US20070112052A9 (en) Methods and compositions for treating headache pain with topical NSAID compositions
US5977176A (en) Compositions for the treatment of warts and herpes
US5576005A (en) Effectiveness of wart removal by compositions including propolis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application